Founded October 2013
Stage Trendlines Incubators Israel
Investor The Trendlines Group
CEO Nir Eliaz
VisiDome is developing an accommodative IOL that offers clear, spectacle-free vision at all distances. The Company’s innovative approach is its simple, effective design that efficiently exploits the eyes’ natural accommodating mechanism and overcomes existing flaws of premium lenses.
The VisiDome IOL is an add-on to standard monofocal IOLs and can be implanted during or after cataract surgery.
The company completed advanced bench testing.
U.S. patent
Delivering true accommodative vision – the ability to change focus – to see up close, far away, and everything in between without glasses continues to be the ultimate goal.
More than 15 years of management and R&D experience in large corporate and medical device start-ups; former CEO and R&D manager ReLeaf Medical; BSc, biomechanical engineering
Director, Ophthalmology Department, Meir Medical Center; professor, Tel Aviv University; medical director, Ein Tal Eye Center; reviewer and board member of ophthalmology journals; founder, Laboratory of Experimental Microsurgery, Meir Medical Center; former director, Department of Ophthalmology, Sackler School of Medicine of Tel Aviv University
20 years’ experience in R&D and managing state-of-the-art technology projects; vast experience in business management; long career as business attorney; graduate of Talpiot (elite Israel Air Force program); LLB; BSc, physics and mathematics, Tel Aviv University
